CAPR vs PODD · $1.62B cap vs P/E 34, rev $2.07B
Capricor Therapeutics Inc (CAPR) versus Insulet Corporation (PODD) — a side-by-side from cached financials, not a winner call.
Capricor Therapeutics Inc (CAPR) is a biotechnology company listed on NASDAQ.
Insulet Corporation (PODD) is a medical devices company listed on NASDAQ.
Latest reported CAPR revenue for 2025-12-31 was $0. Net income was -$105.0M. Revenue was down 100.0% from 2024-12-31 to 2025-12-31. CAPR currently screens at market cap $1.62B.
Latest reported PODD revenue for 2024-12-31 was $2.07B. Net income was $418.3M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
CAPR currently screens at market cap $1.62B. PODD currently screens at market cap $9.94B and trailing P/E 33.5.
Not investment advice. Open the CAPR and PODD stock pages for the full models.
Not investment advice.